Neutrophils in Bronchoalveolar Lavage Fluid Indicating the Severity and Relapse of Pulmonary Sarcoidosis

被引:4
|
作者
Feng, Haoshen [1 ]
Yan, Lili [2 ]
Zhao, Yabin [3 ]
Li, Zhenhua [3 ]
Kang, Jian [3 ]
机构
[1] China Med Univ, Dept Pulm & Crit Care Med, Shengjing Hosp, Shenyang, Peoples R China
[2] Jinzhou Med Univ, Dept Pulm & Crit Care Med, Affiliated Hosp 1, Jinzhou, Peoples R China
[3] China Med Univ, Inst Resp Dis, Dept Pulm & Crit Care Med, Affiliated Hosp 1, Shenyang, Peoples R China
基金
国家重点研发计划;
关键词
pulmonary sarcoidosis; neutrophils; bronchoalveolar lavage fluid; severity; relapse; MATRIX METALLOPROTEINASES; SEVERE ASTHMA; CELLS; TARGETS;
D O I
10.3389/fmed.2021.787681
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundPulmonary sarcoidosis is a highly heterogeneous granulomatous disease without any specific symptoms and manifestations. Neutrophils in bronchoalveolar lavage fluid (BALF) have been proposed to indicate the severity and prognosis of pulmonary sarcoidosis, but this needs confirmation in patients from different populations due to the heterogeneity of the disease. This study aimed to determine the characteristics of patients with pulmonary sarcoidosis in northeastern China and to explore the relationship between neutrophils in BALF and the severity of pulmonary sarcoidosis. MethodsWe enrolled 432 patients who were diagnosed with pulmonary sarcoidosis in this retrospective study. The symptoms, extrapulmonary involvement, forced vital capacity percentage predicted (FVC % pred), and diffusing capacity of the lung for carbon monoxide percentage predicted (DLco % pred) were recorded. BAL was performed in 319 patients, and the results of a cellular examination of BALF were collected. A total of 123 patients who received corticosteroid treatment were followed up for at least 12 months, and the outcomes were recorded. ResultsCough was the most common symptom, and cutaneous involvement was the most common extrapulmonary manifestation in 304 (70.4%) and 82 (19.0%) patients, respectively. The percentages of patients with high neutrophil counts in BALF (>3%) were higher at Stages 2 and 3 compared with Stages 0 and 1 (33.2 vs. 19.4%, p = 0.007), although the percentages of neutrophils in BALF showed no difference between patients at Stages 0, 1, 2, and 3. Patients with high neutrophil counts in BALF had lower FVC % pred compared with the other patients (79.5 +/- 18.2 vs. 84.9 +/- 14.5%, p = 0.025) and were prone to relapse after corticosteroids were tapered. High neutrophil counts in BALF were independently associated with relapse after corticosteroids were tapered in a binary logistic regression analysis (p = 0.027). ConclusionsPatients with pulmonary sarcoidosis lacked specific symptoms and manifestations. The neutrophil count in BALF could indicate the severity and outcomes of pulmonary sarcoidosis.
引用
收藏
页数:9
相关论文
共 50 条
  • [11] Chemokines in the bronchoalveolar lavage fluid of patients with sarcoidosis
    Sugiyama, Y
    Kasahara, T
    Mukaida, N
    Matsushima, K
    Kitamura, S
    INTERNAL MEDICINE, 1997, 36 (12) : 856 - 860
  • [12] Levels of Transferrin in Bronchoalveolar Lavage Fluid in Sarcoidosis
    Masahiko Shigemura
    Yasuyuki Nasuhara
    Satoshi Konno
    Takeshi Hattori
    Chikara Shimizu
    Kazuhiko Matsuno
    Masaharu Nishimura
    Lung, 2010, 188 : 151 - 157
  • [13] PREDICTIVE VALUE OF BRONCHOALVEOLAR LAVAGE IN PULMONARY SARCOIDOSIS
    VERSTRAETEN, A
    DEMEDTS, M
    VERWILGHEN, J
    VANDENEECKHOUT, A
    MARIEN, G
    LACQUET, LM
    CEUPPENS, JL
    CHEST, 1990, 98 (03) : 560 - 567
  • [14] VALUE OF REPEAT BRONCHOALVEOLAR LAVAGE IN PULMONARY SARCOIDOSIS
    FOLEY, NM
    TUNG, K
    CORAL, AP
    JAMES, DG
    JOHNSON, NMCI
    THORAX, 1988, 43 (03) : P239 - P239
  • [15] ULTRASTRUCTURE OF BRONCHOALVEOLAR LAVAGE CELLS IN PULMONARY SARCOIDOSIS
    DANEL, C
    DEWAR, A
    CORRIN, B
    TURNERWARWICK, M
    CHRETIEN, J
    THORAX, 1983, 38 (03) : 223 - 223
  • [16] Endostatin and Cathepsin-V in Bronchoalveolar Lavage Fluid of Patients with Pulmonary Sarcoidosis
    Naumnik, W.
    Ossolinska, M.
    Plonska, I.
    Chyczewska, E.
    Niklinski, J.
    LUNG CANCER AND AUTOIMMUNE DISORDERS, 2015, 833 : 55 - 61
  • [17] BRONCHOALVEOLAR LAVAGE FOR THE EVALUATION OF PULMONARY SARCOIDOSIS TREATMENT
    GALLUCCIO, G
    MEDICINA-RIVISTA DELLA ENCICLOPEDIA MEDICA ITALIANA, 1987, 7 (02): : 193 - 195
  • [18] UNIFORMITY OF BRONCHOALVEOLAR LAVAGE IN PATIENTS WITH PULMONARY SARCOIDOSIS
    PETERSON, MW
    NUGENT, KM
    JOLLES, H
    MONICK, M
    HUNNINGHAKE, GW
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1988, 137 (01): : 79 - 84
  • [19] Neurotrophin system activation in bronchoalveolar lavage fluid immune cells in pulmonary sarcoidosis
    Ricci, A
    Mariotta, S
    Saltini, C
    Falasca, C
    Giovagnoli, MR
    Mannino, F
    Graziano, P
    Sciacchitano, S
    Amenta, F
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2005, 22 (03) : 186 - 194
  • [20] ONCOSTATIN M IN BRONCHOALVEOLAR LAVAGE CORRELATES WITH THE SEVERITY OF SARCOIDOSIS
    Guber, A.
    Jawad, A. Q.
    Salamon, P.
    Mekori, Y. A.
    Shitrit, D.
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2013, 30 (03) : 194 - 200